Annals of the Rheumatic Diseases
@ard.eular.org
ARD is the leading rheumatology journal and it is committed to promoting the highest standards of scientific exchange and education.
Pinned
Annals of the Rheumatic Diseases | Journal | ScienceDirect.com by ElsevierScienceDirect
Read the latest articles of Annals of the Rheumatic Diseases at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
www.sciencedirect.com
📢 Welcome to the ARD BlueSky
Channel!
👉🏻 Follow along for the latest updates on published articles and more!
🎤 Stay tuned also for live coverage from #EULAR2025 Congress taking place in Barcelona on 11-14 June 2025.
📖 Browse the journal at www.sciencedirect.com/journal/anna...
Channel!
👉🏻 Follow along for the latest updates on published articles and more!
🎤 Stay tuned also for live coverage from #EULAR2025 Congress taking place in Barcelona on 11-14 June 2025.
📖 Browse the journal at www.sciencedirect.com/journal/anna...
Reposted by Annals of the Rheumatic Diseases
📰NEWS ALERT! The Annals of the Rheumatic Diseases confirms its status as top-ranking journal in rheumatology.
📖 Read the #eularPressRelease 👉https://pulse.ly/ijbhsjenog
📖 Read the #eularPressRelease 👉https://pulse.ly/ijbhsjenog
June 26, 2025 at 2:00 PM
📰NEWS ALERT! The Annals of the Rheumatic Diseases confirms its status as top-ranking journal in rheumatology.
📖 Read the #eularPressRelease 👉https://pulse.ly/ijbhsjenog
📖 Read the #eularPressRelease 👉https://pulse.ly/ijbhsjenog
Reposted by Annals of the Rheumatic Diseases
🙌Thank you for attending the #EULAR2025 Congress!
We hope you had a memorable experience!
📺Access the On-demand Congress Platform until 31 December 2025 👉 https://pulse.ly/vl0sg17x4k
✈️We Look forward to seeing you at #EULAR2026 in London!
#EULAR #EULAR2025 #Rheumatology
We hope you had a memorable experience!
📺Access the On-demand Congress Platform until 31 December 2025 👉 https://pulse.ly/vl0sg17x4k
✈️We Look forward to seeing you at #EULAR2026 in London!
#EULAR #EULAR2025 #Rheumatology
June 17, 2025 at 11:19 AM
🙌Thank you for attending the #EULAR2025 Congress!
We hope you had a memorable experience!
📺Access the On-demand Congress Platform until 31 December 2025 👉 https://pulse.ly/vl0sg17x4k
✈️We Look forward to seeing you at #EULAR2026 in London!
#EULAR #EULAR2025 #Rheumatology
We hope you had a memorable experience!
📺Access the On-demand Congress Platform until 31 December 2025 👉 https://pulse.ly/vl0sg17x4k
✈️We Look forward to seeing you at #EULAR2026 in London!
#EULAR #EULAR2025 #Rheumatology
#EULAR2025 Pearls of wisdom from the difficult cases of #SLE #pregnancy 🤰🦋
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
June 14, 2025 at 12:14 PM
#EULAR2025 Pearls of wisdom from the difficult cases of #SLE #pregnancy 🤰🦋
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
🟢pre-pregnancy multidisciplinary risk stratification
🟠tailored treatment and monitoring
🟣compatibility of drugs
🟤T2T strategy: reduce & discontinue steroids
🔵shared-decision should be guided by benefit-risk assessment
🎤 Ricardo J. O. Ferreira presented the HPR highlights during the closing plenary session of #EULAR2025.
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
June 14, 2025 at 12:02 PM
🎤 Ricardo J. O. Ferreira presented the HPR highlights during the closing plenary session of #EULAR2025.
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
A great way to reflect on key advances, inspiring talks and shared perspectives from the HPR community.
posted by thomasdavergne.bsky.social
Reposted by Annals of the Rheumatic Diseases
💥 The 3 “Move Together” sessions were a great success at #EULAR2025!
Hands-on, inclusive, and packed with practical tools to bring exercise science into daily care for people with RMDs.
A huge thank you to all who joined us!
posted by thomasdavergne.bsky.social
Hands-on, inclusive, and packed with practical tools to bring exercise science into daily care for people with RMDs.
A huge thank you to all who joined us!
posted by thomasdavergne.bsky.social
June 14, 2025 at 11:57 AM
💥 The 3 “Move Together” sessions were a great success at #EULAR2025!
Hands-on, inclusive, and packed with practical tools to bring exercise science into daily care for people with RMDs.
A huge thank you to all who joined us!
posted by thomasdavergne.bsky.social
Hands-on, inclusive, and packed with practical tools to bring exercise science into daily care for people with RMDs.
A huge thank you to all who joined us!
posted by thomasdavergne.bsky.social
Highlights #EULAR2025 from the PARE Sessions by Michael Poelzi :
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
June 14, 2025 at 11:44 AM
Highlights #EULAR2025 from the PARE Sessions by Michael Poelzi :
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
🔹 Digital tools are promising
🔹 Co-creation, inclusion, and safe care spaces are essential
🔹 Pain, fatigue, sexual and mental health must be seen
🔹 Communication is everything.
#HealthEquity #DigitalHealth
IH
🎯 At #EULAR2025, Rafael Prieto Moreno reminded us:
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
June 14, 2025 at 11:02 AM
🎯 At #EULAR2025, Rafael Prieto Moreno reminded us:
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
✔️ Accessibility of digital health is good, but not perfect
✔️ Co-creation must be context-adapted
✔️ Equity must be designed—not assumed
A strong case for inclusive digital rehab tools.
posted by thomasdavergne.bsky.social
📊 At #EULAR2025, Loreto Carmona illustrated how social determinants shape RA outcomes in Spain — through the compelling case of a woman living with RA.
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
June 14, 2025 at 10:58 AM
📊 At #EULAR2025, Loreto Carmona illustrated how social determinants shape RA outcomes in Spain — through the compelling case of a woman living with RA.
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
A powerful reminder that health inequalities are lived realities.
posted by thomasdavergne.bsky.social
🧪 Late-breaking APEX trial results!
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 14, 2025 at 10:54 AM
🧪 Late-breaking APEX trial results!
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
In active PsA pts (≥3 TJC/SJC, CRP ≥0.3, erosions on X-ray), GUS Q4W & Q8W 🆚 PBO showed:
🦴 Less radiographic progression at W24 (vdH-S: 0.55/0.54 vs 1.35; P=0.002/<0.001)
💪 Higher ACR20 responses
#EULAR2025
Posted by @jgletarouilly.bsky.social
After GRAPPA, it's time for EULAR to its points to consider and definitions of difficult-to-manage and treatment-refractory PsA
#EULAR2025
Posted by @jgletarouilly.bsky.social
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 14, 2025 at 10:33 AM
After GRAPPA, it's time for EULAR to its points to consider and definitions of difficult-to-manage and treatment-refractory PsA
#EULAR2025
Posted by @jgletarouilly.bsky.social
#EULAR2025
Posted by @jgletarouilly.bsky.social
Reposted by Annals of the Rheumatic Diseases
👏 This morning at #EULAR2025, Lucy Brading shared the co-design process behind D-MAPP — a digital self-management app for distal upper limb MSDs.
A great example of meaningful patient involvement from day one.
posted by thomasdavergne.bsky.social
A great example of meaningful patient involvement from day one.
posted by thomasdavergne.bsky.social
June 14, 2025 at 8:07 AM
👏 This morning at #EULAR2025, Lucy Brading shared the co-design process behind D-MAPP — a digital self-management app for distal upper limb MSDs.
A great example of meaningful patient involvement from day one.
posted by thomasdavergne.bsky.social
A great example of meaningful patient involvement from day one.
posted by thomasdavergne.bsky.social
Health literacy isn’t about “high” or “low”, it’s about challenges, needs, and diversity.
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
June 14, 2025 at 7:58 AM
Health literacy isn’t about “high” or “low”, it’s about challenges, needs, and diversity.
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
Powerful reminder from Mark Bakker at today’s #EULAR2025 session on health literacy in rheumatology.
#Rheumatology #HealthEquity
IH
📚 Jet Veldhuijzen van Zanten presented the updated EULAR recommendations on patient education for people with inflammatory arthritis at #EULAR2025.
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
June 14, 2025 at 7:55 AM
📚 Jet Veldhuijzen van Zanten presented the updated EULAR recommendations on patient education for people with inflammatory arthritis at #EULAR2025.
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
A key milestone for HPRs 👩⚕️👨⚕️
The full publication will be available soon.
posted by thomasdavergne.bsky.social
🚺 #EULAR2025 RMD & #Menopause: is there a place for HRT? YES!
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
June 14, 2025 at 7:34 AM
🚺 #EULAR2025 RMD & #Menopause: is there a place for HRT? YES!
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
🟪 In perimenopausal women with RMD, let's consider the role of hormonal changes in the fluctuations of symptoms.
🟪 Individualized approach is the key
🟪 Benefits of HRT may outweigh the slighty increased risks in most women
#reprohealth
🧬 Does MTX with 1st ADA shot prevent anti-ADA antibodies in axSpA?
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
June 13, 2025 at 4:52 PM
🧬 Does MTX with 1st ADA shot prevent anti-ADA antibodies in axSpA?
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
🇫🇷 MESYNAD RCT: ❌ No difference at 6mo
💉 MTX+ADA = ADA alone
No added benefit for immunogenicity.
#EULAR2025 #POS0889
Posted by @jgletarouilly.bsky.social
📊 RABBIT-SpA registry insights:
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 12, 2025 at 4:09 PM
📊 RABBIT-SpA registry insights:
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹 8.5% met ASAS D2M axSpA criteria (75/881)
🔹 2.5% met TR criteria (22/881)
👩 D2M-axSpA patients = more female, less HLA-B27
Results similar to those from the Dutch cohort
#EULAR2025
Posted by @jgletarouilly.bsky.social
🧠✨GRAPPA Definitions
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 12, 2025 at 3:47 PM
🧠✨GRAPPA Definitions
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
🔹Complex-to-Manage PsA (C2M PsA)
➡️ Persistent symptoms despite treatment with≥1 b/tsDMARD 💊
🔸 Difficult-to-Treat PsA (D2T PsA)
➡️ Characterized by failure to respond to ≥3 prior PsA therapies with different MoA 🔄💥
#EULAR2025
Posted by @jgletarouilly.bsky.social
Gaslighting and Unconscious Bias in Rheumatology , a powerful session at #EULAR2025 exposing the harm caused within and beyond clinical teams.
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
June 12, 2025 at 1:34 PM
Gaslighting and Unconscious Bias in Rheumatology , a powerful session at #EULAR2025 exposing the harm caused within and beyond clinical teams.
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
Disagree Well. Speak truth. Challenge bias.
#Gaslighting #UnconsciousBias #EULAR2025
IH
Reposted by Annals of the Rheumatic Diseases
📲 Inspiring work from Deniz Bayraktar at #EULAR2025!
She adapted the SARAH self-rehab programme for people with RA in Türkiye — and delivered it via WhatsApp! 🇹🇷💬
A brilliant example of accessible care in action.
She adapted the SARAH self-rehab programme for people with RA in Türkiye — and delivered it via WhatsApp! 🇹🇷💬
A brilliant example of accessible care in action.
June 12, 2025 at 9:24 AM
📲 Inspiring work from Deniz Bayraktar at #EULAR2025!
She adapted the SARAH self-rehab programme for people with RA in Türkiye — and delivered it via WhatsApp! 🇹🇷💬
A brilliant example of accessible care in action.
She adapted the SARAH self-rehab programme for people with RA in Türkiye — and delivered it via WhatsApp! 🇹🇷💬
A brilliant example of accessible care in action.
Reposted by Annals of the Rheumatic Diseases
👥 Are you a health professional in rheumatology?
Join the LinkedIn group to connect, share & grow with the HPR community!
🔗 www.linkedin.com/groups/10072...
Let’s build bridges across borders 🌍
posted by thomasdavergne.bsky.social
#EULAR2025 #HPR
Join the LinkedIn group to connect, share & grow with the HPR community!
🔗 www.linkedin.com/groups/10072...
Let’s build bridges across borders 🌍
posted by thomasdavergne.bsky.social
#EULAR2025 #HPR
June 12, 2025 at 8:33 AM
👥 Are you a health professional in rheumatology?
Join the LinkedIn group to connect, share & grow with the HPR community!
🔗 www.linkedin.com/groups/10072...
Let’s build bridges across borders 🌍
posted by thomasdavergne.bsky.social
#EULAR2025 #HPR
Join the LinkedIn group to connect, share & grow with the HPR community!
🔗 www.linkedin.com/groups/10072...
Let’s build bridges across borders 🌍
posted by thomasdavergne.bsky.social
#EULAR2025 #HPR
📢 Reminder at #EULAR2025
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
June 12, 2025 at 8:16 AM
📢 Reminder at #EULAR2025
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
🧠 HPR Move Together: Moving Science into Practice
📍Walkway Hall 6 & 7 – Upper Floor
🗓️ June 12 | 12:15–13:15
🗓️ June 13 | 12:15–13:15
🗓️ June 14 | 10:30–11:30
Let’s move science into action!
posted by thomasdavergne.bsky.social
June 12, 2025 at 7:35 AM
Hello from Day 2 of EULAR Congress!
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
June 12, 2025 at 7:06 AM
Hello from Day 2 of EULAR Congress!
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.
#EULAR2025 #PosterTour #Spondyloarthritis
IH
🔬SPEED RCT in patients with PsA and poor prognostic factors
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
June 12, 2025 at 5:45 AM
🔬SPEED RCT in patients with PsA and poor prognostic factors
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
🎯 Primary Endpoint: Mean PASDAS at 24 weeks
✅ Combination csDMARDs** > Standard step-up
✅️TNFi** > Standard step-up
❌ No significant difference between Combination csDMARDs and TNFi
#EULAR2025
Posted by @jgletarouilly.bsky.social
📍Foot OA affects 1 in 6 adults >50 and is often disabling.
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social
June 11, 2025 at 3:29 PM
📍Foot OA affects 1 in 6 adults >50 and is often disabling.
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social
🩺 Clinical ID is easier for 1st MTP than midfoot OA.
💉 Hyaluronan no better than saline.
👟 Prefab orthoses = rocker soles (but better adherence).
Final take-home messages from Hylton Menz at #EULAR2025
posted by thomasdavergne.bsky.social